Marc Feldmann

Marc Feldmann is the founder of Nuon Therapeutics, Inc. founded in 2006.
Dr. Feldmann is the founder of CannBioRex Pharmaceuticals Corp.
founded in 2018, holding the title of Co-Chairman since 2018.
Dr. Feldmann is the founder of Enosi Life Sciences Corp.
founded in 2018, holding the title of Director since 2018.
Dr. Feldmann is also the founder of ReFormation Pharmaceuticals Corp.,Katexco Pharmaceuticals Corp.,ETHZilla Corp.,Etheros Pharmaceuticals Corp...
Dr. Feldmann is Non-Executive Chairman at HemoGenyx Pharmaceuticals Plc since 2018.
Dr. Feldmann is Co-Chairman at 180 Life Corp.
since 2019.
Dr. Feldmann is Director at StormBio, Inc. Dr. Feldmann is Director at Lupus Research Alliance, Inc. Dr. Feldmann is Professor at the University of Oxford since 2011.
Dr. Feldmann is Member at the National Academy of Sciences.
Dr. Feldmann is Professor-Emeritus at the Kennedy Institute of Rheumatology.
Dr. Feldmann was Co-Executive Chairman at KBL Merger Corp.
IV.
Dr. Feldmann earned a doctorate from the University of Melbourne in 1972.